COMMUNIQUÉS West-GlobeNewswire

AzurRx BioPharma Reaches Enrollment Target for Phase II OPTION Clinical Trial
23/05/2019
Enrollment in AzurRx’s Phase II OPTION study has reached target of 30-35 patients Screening activities have been completed in AzurRx’s Phase II Option study Top-line data expected in Summer 2019 NEW YORK, May 23, 2019 ( [...]
Todos Medical Receives Approval from Israeli Ministry of Health (AMAR) to Market and Sell its Breast Cancer Screens in Israel
23/05/2019
REHOVOT, Israel, May 23, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection of cancer and [...]
Immutep Announces European Patent Grant for Eftilagimod Alpha in Chemo-Immunotherapy
23/05/2019
SYDNEY, Australia, May 23, 2019 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune [...]
RedHill Biopharma to Present at 2019 BIO International Convention
23/05/2019
TEL-AVIV, Israel and RALEIGH, N.C., May 23, 2019 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL ) (Tel-Aviv Stock Exchange: RDHL ) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]
BioSig Allowed First Key US Patent Claims for its PURE EP™ System
23/05/2019
Santa Monica, CA, May 23, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet [...]
Albireo Announces Data on Pediatric Cholestatic Liver Diseases to be Presented at the 2019 ESPGHAN Annual Meeting
23/05/2019
BOSTON, May 23, 2019 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that clinical data and [...]
Orchestra BioMed™ Presents Clinical Data at EuroPCR 2019 Demonstrating Safety and Efficacy of BackBeat Cardiac Neuromodulation Therapy (CNT)
23/05/2019
Novel implantable bioelectronic treatment delivers immediate, substantial, and sustained reduction in blood pressure Data showed 14.2 mmHg reduction in 24-hour ambulatory systolic blood pressure at three months and 23.4 [...]
Diffusion Pharmaceuticals Receives Notice of Intention to Grant a Patent Related to Use of TSC in Combination with tPA in Ischemic Stroke from European Patent Office
23/05/2019
Two Additional European Patents Issued CHARLOTTESVILLE, Va., May 23, 2019 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or “the Company”), a cutting-edge biotechnology company developing [...]
Kumulus Vape, spécialiste de lacigarette électronique 100% e-commerce,entre en Bourse
23/05/2019
Corbas, le 23 mai 2019 Kumulus Vape, spécialiste de la cigarette électronique 100% e-commerce, entre en Bourse Kumulus Vape (ISIN : FR0013419876 - Mnémonique : MLVAP), e-commerçant spécialisé dans la vente de cigarettes [...]
Axogen, Inc. to Participate at Upcoming Investor Conferences
23/05/2019
ALACHUA, Fla., May 23, 2019 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today announced that [...]
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference
23/05/2019
THE WOODLANDS, Texas, May 23, 2019 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Jeffrey L. Wade, J.D., Executive Vice President, Corporate and Administrative Affairs and Chief [...]
Tonix Pharmaceuticals Expands Pipeline with Mid-Stage Biologic Candidate TNX-1300 for Cocaine Intoxication
23/05/2019
Phase 2 Program Granted Breakthrough Therapy Designation by FDA Emergency Room Visits for Cocaine Abuse Total More than 500,000 Annually in U.S. NEW YORK, May 23, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding [...]
Solo Growth Corp™ Announces Operational Update and First Quarter 2019 Results
23/05/2019
CALGARY, Alberta, May 23, 2019 (GLOBE NEWSWIRE) -- Solo Growth Corp.™ (the “ Company ” or “ Solo Growth ”) (TSXV: SOLO) (WKN:A2PBMC), a cannabis retailer operating as YSS TM with the vision to become a premier retailer [...]
Brainsway Ltd. to Host First Quarter 2019 Financial Results Conference Call on May 29, 2019
23/05/2019
JERUSALEM and HACKENSACK, N.J., May 23, 2019 (GLOBE NEWSWIRE) -- Brainsway Ltd. (NASDAQ & TASE: BWAY) (“Brainsway”), a commercial stage medical device company focused on the development and sale of non-invasive [...]
Dentsply Sirona Board Approves Relocation of Headquarters to Charlotte N.C. and Announces CFO Transition Plan
23/05/2019
CHARLOTTE, N.C., May 23, 2019 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), the Dental Solutions Company, today announced that the Board of Directors approved the relocation of the Company [...]
Medcolcanna Announces Commencement of Trading on the TSX Venture Exchange Under the Symbol MCCN and Other Corporate Matters
23/05/2019
Medcolcanna to Acquire Innovative CBD Products B.V. as Part of Continued Strategic Initiatives BOGOTÁ, Colombia, May 23, 2019 (GLOBE NEWSWIRE) -- Medcolcanna Organics Inc . (TSX-V: MCCN) (“ Medcolcanna ” or the “ [...]
So-Young to Report First Quarter 2019 Financial Results on May 30, 2019
23/05/2019
BEIJING, May 23, 2019 (GLOBE NEWSWIRE) -- So-Young International Inc. (NASDAQ: SY) (“So-Young” or the “Company”), the most popular online destination for discovering, evaluating and reserving medical aesthetic services [...]
Mesoblast Keynote Presentations to Feature at 2019 Annual Meeting of the International Society for Cell and Gene Therapy
23/05/2019
MELBOURNE, Australia; and NEW YORK, May 23, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader in cellular medicines for inflammatory diseases, will feature at the International Society for [...]
PCI Biotech: First patient enrolled in the fimaChem pivotal RELEASE study
23/05/2019
Oslo (Norway), 23 May 2019 – PCI Biotech (OSE: PCIB), a cancer focused clinical-stage company developing innovative therapeutics that address significant unmet medical needs today announced first patient enrolled in the [...]

Pages